PatientsVille.com Logo

Type and Diaformin

PatientsVille

Type Symptoms and Causes

Diabetes means your blood glucose, or blood sugar, levels are too high. With Type 1 diabetes, your pancreas does not make insulin. Insulin is a hormone that helps glucose get into your cells to give them energy. Without insulin, too much glucose stays in your blood. Over time, high blood glucose can lead to serious problems with your heart, eyes, kidneys, nerves, and gums and teeth.

Type 1 diabetes happens most often in children and young adults but can appear at any age. Symptoms may include

  • Being very thirsty
  • Urinating often
  • Feeling very hungry or tired
  • Losing weight without trying
  • Having sores that heal slowly
  • Having dry, itchy skin
  • Losing the feeling in your feet or having tingling in your feet
  • Having blurry eyesight

A blood test can show if you have diabetes. If you do, you will need to take insulin for the rest of your life. A blood test called the A1C can check to see how well you are managing your diabetes.

NIH: National Institute of Diabetes and Digestive and Kidney Diseases

Check out the latest treatments for type

type treatment research studies

Diaformin clinical trials, surveys and public health registries


Find Drug Side Effect reports



Diaformin Side Effects

Fatigue (67)
Arterial Disorder (53)
Hunger (46)
Dyspnoea (45)
Blood Glucose Increased (34)
Angioneurotic Oedema (24)
Weight Decreased (21)
Vomiting (19)
Dehydration (18)
Renal Failure Acute (15)
Pernicious Anaemia (15)
Hypoglycaemia (14)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

<b>i feel sick all the time im on diaformin 850</b>

Been overdosed over nine months on 5700mg of Diaformin per dayby my GP. Had lost weight, loss of appetite anaemia B12 deficiency vitamin D deficiency lethagy pains in back on exertion etc. Rushed to hospital, no recordable blood sugar, acut

Dont get discouraged, I am 21 years old and got diagnosed with diabetes when i was 15. I hated it for a little while then i thought well i have to live with it so i better make the best of it. I, just like anyone, wanted to live an ordinary teen life

Dosage 3x500mg daily. Nausea, loss of appetite, Possibly also constipation.On Thyroxine,Tritace,Cardizem,Natrilix,Lipitor,Cartia. Because of the nausea myDiet therefore not well balanced any more which affects

Had to increase dosage to 1000mg twice a day. Immediately began to find it difficult to summon any energy to do any normal day to day acttivities eg washing, cooking. Diarhoea, lethargy, increase in thirst ( nothing quen

I am 14 and type one diabetic, and i just want it to go away so i can live a normal happy life, i would like to drink to see what its like (typical teen) but i really dont want diabetes , so i don't really care about it, my mum and dad get worried be

I am a <b>Cancer patient with Diabetes Type 2 and dependent on Human Insulin for many years. I am on Insulin on two times a day. I was on chemotherapy several times and many cycles. My sugar level is still unconrolled.&n

I am a type 2 diabetic 62 years of age, female,and recently my doctor has increased my Diafomin 1000g from two a day to three times a day...she has also stated me on a new Blood Presssure tablet called Avapro HCT 300/25 since I started them I have

I am diaform 500mg 3 times a day each time two tablets I have running stomach and I am very tired and very stress My diabetic is type 2

I BEGAN LOSING MY HAIR, AND AFTER FOUR VISITS BACK TOO THE DOC THAT HE REALLY TOOK NOTICE OF WHAT I WAS SAYING. EVERY TIME I HAD SHOWER OR WASHED MY HAIR, THERE WAS HAIR EVERY WHERE IN THE BOTTOM OF SHOWER. HE NOW HAS CHANGED ME FROM DIAFORIN TOO DIA

Hi! am looking Operational and Installation manual for this type of x-ray machine Summit AmeriComp control console, with power module SHF 310 and other accessories of it. Well! let me give you this control console picture may be you will aware of

I WANT FRIENDS WHO HAVE TYPE 1DIABETIC

sorry type errors if i could do it over i would have never taken this drug if i had only know .. wahtever you do don't just trust your doctor is doing the right thing or even a good thing for you like i did do

My grand father was diagnosed with dementiaalzheimer's type and was prescribed Aricept. After he started taking Aricept, his condition have gotten worse and he actually died yesterday. He was 83 years old.

<span style='color: #808080;'><b>Describe Your Henoch-Schonlein purpura from INFLUENZA (H1N1) (H1N1 (MONOVALENT) SANOFI) 2010 Experience Here:</b> Vicious headaches, rash on legs and trunk, transient, cystitis type fee

After being exposed to bright light my vision field is spotty with bright lights. I have a similar experince when I'm hypoglycemic often my first sympto but this type is unrelated to my BLOOD SUGAR. mY LATEST MEDS ADDED ARE Cardizem for A-fib, coumad

After just 7 days of starting pioglitazone(15 mg.daily) ,I developed loss of taste for mainly sugar and salt,but unfortunatyely i couldnot guess pioglitazone as possible cause. I am type 2 diabetic and hypertensive and taking metformin,glimeperide,li

After taking 500mg of fortamet for two weeks i am having blured vision . i am type 2 diabetic.

Another thing, can a patient with diabetes type 1 and previously suffered and recovered from Multiple sclerosis ( M-S ) use Spasfon ???

Asked my Cardiologist about this drug. He said I was a candidate, but said he had two patients that reacted to it. One had her lips peel off and the other had some type of negative reaction. We agreed to 'wait and see' as there just haven't been t

Type Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Unknown  Effects of Adjunctive Metformin on Metabolic Profiles in Clozapine-treated Schizophrenic Patients
Conditions: Obesity;   Metabolic Syndrome;   Schizophrenia
Interventions: Drug: Metformin;   Drug: placebo
Outcome Measures: body weight change;   metabolic features
2 Recruiting The Effects of Metformin on Functional Capacity in Individuals With Peripheral Artery Disease-Related Intermittent Claudication and Abnormal Glucose Metabolism
Conditions: Peripheral Arterial Disease;   Intermittent Claudication;   Glucose Metabolism Disorders
Interventions: Drug: Metformin;   Drug: Placebo
Outcome Measures: Change in pain-free walking time;   Change in maximum walking time;   Change in questionnaire-based markers of quality of life / perceived functional capacity;   Change in endothelial function;   Change in skeletal muscle blood flow response to insulin;   Change in skeletal muscle blood flow response to acute exercise;   Change in insulin sensitivity;   Change in objectively measured physical activity / sedentary behaviour in the daily life setting.
3 Recruiting A Study To Evaluate The Efficacy And Safety Of Ertugliflozin In Participants With Type 2 Diabetes Mellitus And Inadequate Glycemic Control On Metformin Monotherapy (MK-8835-007)
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Ertugliflozin 5 mg;   Drug: Ertugliflozin 15 mg;   Drug: Placebo to Ertugliflozin;   Other: Glimepiride;   Drug: Placebo to Glimepiride;   Biological: Basal Insulin;   Drug: Metformin
Outcome Measures: Change from Baseline in Hemoglobin A1c;   Number of Participants Experiencing An Adverse Event (AE);   Number of Participants Discontinuing Study Treatment Due to an AE;   Change from Baseline in Fasting Plasma Glucose;   Change from Baseline in Body Weight at Week 26;   Number of participants with a HbA1c of <7% (53 mmol/mol) at Week 26;   Change from Baseline in Systolic Blood Pressure;   Change from Baseline in Diastolic Blood Pressure;   Change from Baseline in Bone Mineral Density at Week 26;   Change from Baseline in Bone Mineral Density at Week 52;   Change from Baseline in Bone Mineral Density at Week 104;   Number of participants with HbA1c <=6.5% (48 mmol/mol) at Week 26;   Number of participants requiring glycemic rescue therapy up to Week 26;   Time to glycemic rescue therapy up to Week 26;   Change from baseline in bone biomarkers at Week 26;   Change from baseline in bone biomarkers at Week 52;   Change from baseline in bone biomarkers at Week 104
4 Recruiting A Study of the Efficacy and Safety of Ertugliflozin Monotherapy in the Treatment of Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control Despite Diet and Exercise (MK-8835-003)
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Ertugliflozin (5 mg);   Drug: Ertugliflozin (10 mg);   Drug: Placebo to Ertuglifozin;   Drug: Metformin;   Drug: Placebo to Metformin
Outcome Measures: Change from Baseline In Hemoglobin A1c (HbA1c) at Week 26;   Number of Participants Experiencing An Adverse Event (AE);   Number of Participants Discontinuing Study Treatment Due to an AE;   Change from Baseline in Fasting Plasma Glucose (FPG) at Week 26;   Change from Baseline in Body Weight at Week 26;   Number of Participants with a HbA1c <7% (53 mmol/mol) at Week 26;   Change from Baseline in 2-hour Post-prandial Plasma Glucose at Week 26;   Change from Baseline in Systolic Blood Pressure at Week 26;   Change from Baseline in Diastolic Blood Pressure at Week 26